FSSAI initiates action against Nestlé India over infant-food claims
India’s food regulator has flagged Nestlé India’s infant-food labels and advertising claims, including references to “5 HMOs” and easy-to-digest whey, alongside alleged biotin and nutrition-declaration discrepancies.
What happened
FSSAI has initiated action against Nestle India over alleged non-compliant infant-food label and advertising claims, including “5 HMOs” and easy-to-digest whey,
Key facts
- 5 HMOs
- 6 manufacturing facilities
- approximately 7,000 workers
- 1.7% share-price drop
- 77.01 CHF
What changed
FSSAI has initiated action against Nestle India over alleged non-compliant infant-food label and advertising claims, including “5 HMOs” and easy-to-digest whey, alongside flagged biotin levels and nutritional-declaration discrepancies.
Why this matters
The FSSAI action raises near-term regulatory, remediation and reputational risk for Nestlé India’s infant-nutrition franchise, though the financial impact depends on the scope of required changes or penalties.
What to watch
- Whether FSSAI issues a show-cause notice, product-specific prohibition, recall direction, monetary penalty or prosecution.
- Publication of testing results or specific findings on biotin levels, nutrition declarations or claim substantiation.
- Nestlé India statements on affected brands, batches, relabelling timelines and any sales impact.
- Expansion of inspections or notices to other infant-formula and baby-food manufacturers.
- Retailer, pharmacy and e-commerce actions such as delisting, claim edits or inventory holds.